Android app on Google Play

Anthera Pharma (ANTH) Files $100M Mixed Shelf

January 18, 2012 6:23 AM EST Send to a Friend
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.




You May Also Be Interested In


Related Categories

Equity Offerings

Add Your Comment